trending Market Intelligence /marketintelligence/en/news-insights/trending/4_73PXMvIqjvcgnd830cng2 content esgSubNav
In This List

Catalyst Biosciences prices $18M underwritten public offering

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Catalyst Biosciences prices $18M underwritten public offering

Catalyst Biosciences Inc. priced a securities offering to raise $18 million in gross proceeds.

The company is issuing class A units and class B units representing a total of 930,000 common shares, 13,350 preferred shares and warrants to purchase another 1.8 million stock of the company.

Class A units were priced at $5 apiece and comprised a common share and a warrant that can be exercised for half of a Catalyst stock at $5.50. Class B units were priced at $1,000 apiece and comprised 1 preferred share and a warrant to purchase 100 common shares at $5.50 per share.

Each preferred share is convertible into 200 common shares of Catalyst Biosciences.

Ladenburg Thalmann & Co. Inc. is the sole book-running manager for the offering which is expected to close by April 12.